Back to Markets
CGCullinan Therapeutics Inc

Cullinan Therapeutics Inc

CGEMNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$16.44

+1.08 (+7.03%)

As of 05/29/26 EDT · USD

Compare
Low: $5.68Current: $16.44High: $16.74

Key Statistics

Open

$15.19

Day High

$16.72

Day Low

$15.00

Prev. Close

$15.36

VolumeShares traded today.

1.76M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$1.01B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-4.42

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$16.74

52W LowLowest price over the past 52 weeks.

$5.68

50D MAAverage closing price over the last 50 trading days.

$14.37

200D MAAverage closing price over the last 200 trading days.

$10.98

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+17.6%

1M

+27.9%

6M

+39.4%

YTD

+62.5%

1Y

+90.2%

About

Patrick Baeuerle is a German-based molecular biologist, immunologist, professor and a biopharmaceutical entrepreneur. Baeuerle is known for his work on tyrosine sulfation of proteins, transcription factor NF-kappaB, and the development of bispecific T-cell engaging antibodies for therapy of cancer.

cullinantherapeutics.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade CGEM

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.